Alterity Therapeutics Ltd 6-K, filed Nov 14, 2022
Alterity Therapeutics Ltd (ATHE)
About this 6-K
Alterity Therapeutics Ltd filed this 6-K on November 14, 2022.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2022
Alterity Therapeutics Limited
(Name of Registrant)
Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____
This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-251647, 333-249311, 333-231417 and 333-250076)
ALTERITY THERAPEUTICS LIMITED
(a development stage enterprise)
The following exhibits are submitted:
| 99.1 | Results of Annual General Meeting |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Alterity Therapeutics Limited | ||
| /s/ Geoffrey P. Kempler | ||
| By: | Geoffrey P. Kempler Chairman | |
Date: November 14, 2022
2
Exhibit 99.1
COMPANY ANNOUNCEMENT
(ASX: ATH, NASDAQ: ATHE)
RESULTS OF ANNUAL GENERAL MEETING
Friday, 11th November 2022
The Company wishes to advise that all resolutions contained in the Notice of Meeting were carried by poll.
In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following page provides information in relation to the proxy votes received for each resolution considered by Members of the Company at the Annual General Meeting held today.
The Chairman voted undirected proxies in his control in favour of all resolutions.
On behalf of the Board
Phillip Hains
Company Secretary
Alterity Therapeutics Limited
| Page 1 of 2 | |||
| Level 3, 62 Lygon Street, Carlton | Telephone: 61 3 9824 5254 | ||
| Victoria Australia 3053 | Facsimile: 61 3 9822 7735 |
| Alterity Therapeutics Limited | ||
| Annual General Meeting | ||
| Friday, 11 November 2022 Results of Meeting |
 | |
The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.
| Resolution details | Instructions given to validly appointed proxies (as at proxy dose) | Number of votes cast on the poll (where applicable) |
Resolution Result | ||||||||||||||||||||||||
| Resolution | Resolution Tvne | For | Against | Proxy’s Discretion | Abstain | For | Against | Abstain* | Carried/ Not Carried | ||||||||||||||||||
| 1 Non-binding resolution to adopt Remuneration Report | Ordinary | 212,121,028 93.79% | 12,039,215 5.32% | 2,019,647 0.89% | 12,192,200 | 214,140,675 94.68% | 12,039,225 5.32% | 12,192,200 | Carried | ||||||||||||||||||
| 2 Re-Election of Director - Mr. Brian Meltzer | Ordinary | 235,773,122 95.41% | 9,095,160 3.68% | 2,255,114 0.92% | 10,475,720 | 238,947,357 96.33% | 9,095,160 3.67% | 10,475,720 | Carried | ||||||||||||||||||
| 3 Approval to refresh and amend 2004 ASX Plan | Ordinary | 213,822,822 93.29% | 13,353,360 5.83% | 2,013,647 0.88% | 11,562,047 | 215,836,469 94.17% | 13,353,360 5.83% | 11,562,047 | Carried | ||||||||||||||||||
| 4 Approval to refresh and amend 2018 ADS Plan | Ordinary | 215,112,595 93.58% | 12,744,600 5.54% | 2,020,114 0.88% | 10,992,587 | 217,132,709 94.46% | 12,744,610 5.54% | 10,992,587 | Carried | ||||||||||||||||||
| 5 Approval of 10% Placement Issue | Special | 235,361,107 91.87% | 18,807,375 7.34% | 2,013,647 0.79% | 2,230,527 | 238,293,865 92.68% | 18,807,385 7.32% | 2,230,527 | Carried | ||||||||||||||||||
| 6 Amendment of Company constitution | Special | 238,259,074 92.96% | 16,018,028 6.25% | 2,032,647 0.79% | 2,148,267 | 241,210,832 93.77% | 16,018,038 6.23% | 2,148,267 | Carried | ||||||||||||||||||
| 7 Ratification of prior issue of shares | Ordinary | 239,926,221 93.69% | 14,132,568 5.52% | 2,013,647 0.79% | 2,335,600 | 242,858,979 94.50% | 14,132,578 5.50% | 2,335,600 | Carried | ||||||||||||||||||
| * | Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll. |
| Page 2 of 2 | |||
| Level 3, 62 Lygon Street, Carlton | Telephone: 61 3 9824 5254 | ||
| Victoria Australia 3053 | Facsimile: 61 3 9822 7735 |